Ga-labeled prostate-specific membrane antigen (PSMA) is a potential tool in the imaging of recurrent prostate cancer. Ga-PSMA imaging is also useful for radiotherapy planning and in targeted therapy with Lu-PSMA.
A few case reports regarding the use of Ga-PSMA in nonprostate cancer malignancies are also reported. We describe the use of Ga-PSMA imaging before Sm-EDTMP bone pain palliation therapy in a 58-year-old hormone refractory prostate cancer patient with extensive bone metastases.
Clinical nuclear medicine. 2016 Apr 06 [Epub ahead of print]
Arun Sasikumar, Ajith Joy, Raviteja Nanabala, M R A Pillai, Boben Thomas
From the *Department of Nuclear Medicine and PET/CT, KIMS-DDNMRC; and †Department of Medical Oncology, KIMS Cancer Centre, KIMS Hospital, Trivandrum, India.